Crystal structure of a human GABAA receptor

Nature

Volumn 512, Issue 7514, 2014, Pages 270-275

  Miller, Paul S ^a   Aricescu, A Radu ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZAMIDINE; CYSTEINE LOOP LIGAND GATED ION CHANNEL RECEPTOR; GLYCAN;

BRAIN; CRYSTAL STRUCTURE; DISEASE; ION; NEUROLOGY;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMAN; HUMAN CELL; N LINKED GLYCOSYLATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE;

EUKARYOTA;

BENZAMIDINES; BINDING SITES; CELL MEMBRANE; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; GABA-A RECEPTOR AGONISTS; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION; HUMANS; MODELS, MOLECULAR; MUTATION; POLYSACCHARIDES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION;

EID: 84905669878     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13293     Document Type: Article

References (82)

1. Rabow, L. E., Russek, S. J. & Farb, D. H. From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse 21, 189-274 (1995).
2. Grenningloh, G. et al. Glycine vs GABA receptors. Nature 330, 25-26 (1987).
3. Simon, J., Wakimoto, H., Fujita, N., Lalande, M. & Barnard, E. A. Analysis of the set of GABAAreceptorgenesinthehumangenome.J. Biol.Chem.279, 41422-41435(2004).
4. Sigel, E. & Steinmann, M. E. Structure, function, and modulation of GABAA receptors. J. Biol. Chem. 287, 40224-40231 (2012).
5. Yip, G. M. et al. A propofol binding site on mammalian GABAA receptors identified by photolabeling. Nature Chem. Biol. 9, 715-720 (2013).
6. Karlin, A. & Akabas, M. H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15, 1231-1244 (1995).
7. Miller, P. S. & Smart, T. G. Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol. Sci. 31, 161-174 (2010).
8. Rudolph, U. & Knoflach, F. Beyond classical benzodiazepines: novel therapeutic potential ofGABAA receptor subtypes.NatureRev.DrugDiscov.10, 685-697 (2011).
9. Li, G. D. et al. Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J. Neurosci. 26, 11599-11605 (2006).
10. Wallner, M., Hanchar, H. J. & Olsen, R. W. Ethanol enhances a4b3d and a6b3d c-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc. Natl Acad. Sci. USA 100, 15218-15223 (2003).
11. Belelli, D. & Lambert, J. J. Neurosteroids: endogenous regulators of the GABAA receptor. Nature Rev. Neurosci. 6, 565-575 (2005).
12. Brejc, K. et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269-276 (2001).
13. Miyazawa, A., Fujiyoshi, Y. & Unwin, N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423, 949-955 (2003).
14. Unwin, N. Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. J. Mol. Biol. 346, 967-989 (2005).
15. Hilf, R. J. & Dutzler, R. X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 452, 375-379 (2008).
16. Bocquet, N. et al. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457, 111-114 (2009).
17. Hibbs, R. E. & Gouaux, E. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474, 54-60 (2011).
18. Nury, H. et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469, 428-431 (2011).
19. Jansen, M., Bali, M. & Akabas, M. H. Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA r1 receptors lacking the large cytoplasmic M3M4 loop. J. Gen. Physiol. 131, 137-146 (2008).
20. Hansen, S. B., Wang, H. L., Taylor, P. & Sine, S. M. An ion selectivity filter in the extracellular domain of Cys-loop receptors reveals determinants for ion conductance. J. Biol. Chem. 283, 36066-36070 (2008).
21. Sauguet, L. et al. Structural basis for ion permeation mechanism in pentameric ligand-gated ion channels. EMBO J. 32, 728-741 (2013).
22. Gurba, K. N., Hernandez, C. C., Hu, N. & Macdonald, R. L. GABRB3 mutation, G32R, associated with childhood absence epilepsy alters a1b3c2L c-aminobutyric acid type A (GABAA) receptor expression and channel gating. J. Biol. Chem. 287, 12083-12097 (2012).
23. Sancar, F. & Czajkowski, C. A GABAA receptor mutation linked to human epilepsy (c2R43Q) impairs cell surface expression of abc receptors. J. Biol. Chem. 279, 47034-47039 (2004).
24. Epi, K. C. et al. De novo mutations in epileptic encephalopathies. Nature 501, 217-221 (2013).
25. Bergmann, R., Kongsbak, K., Sorensen, P. L., Sander, T. & Balle, T. A Unified model of theGABAA receptor comprising agonist and benzodiazepine binding sites. PLoS ONE 8, e52323 (2013).
26. Hansen, S. B. et al. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24, 3635-3646 (2005).
27. Huang, S. et al. Complex between a-bungarotoxin and an a7 nicotinic receptor ligand-binding domain chimaera. Biochem. J. 454, 303-310 (2013).
28. Celie, P. H. et al. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41, 907-914 (2004).
29. Newell, J. G., McDevitt, R. A. & Czajkowski, C. Mutation of glutamate 155 of the GABAA receptor b2 subunit produces a spontaneously open channel: a trigger for channel activation. J. Neurosci. 24, 11226-11235 (2004).
30. Venkatachalan, S. P. & Czajkowski, C. A conserved salt bridge critical for GABAA receptor function and loop C dynamics. Proc. Natl Acad. Sci. USA 105, 13604-13609 (2008).
31. Wagner, D.A., Czajkowski, C. & Jones, M.V. AnarginineinvolvedinGABAbinding and unbindingbutnot gating of theGABAA receptor. J.Neurosci.24, 2733-2741(2004).
32. Mukhtasimova, N., Free, C. & Sine, S. M. Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor. J. Gen. Physiol. 126, 23-39 (2005).
33. Rees, D. C., Congreve, M., Murray, C. W. & Carr, R. Fragment-based lead discovery. Nature Rev. Drug Discov. 3, 660-672 (2004).
34. Lo, W. Y. et al. Glycosylation of b2 subunits regulates GABAA receptor biogenesis and channel gating. J. Biol. Chem. 285, 31348-31361 (2010).
35. Miller, P. S., Da Silva, H. M. & Smart, T. G. Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors. J. Biol. Chem. 280, 37877-37884 (2005).
36. Buhr, A. et al. Functional characterization of the new human GABAA receptor mutation b3(R192H). Hum. Genet. 111, 154-160 (2002).
37. Dellisanti, C. D., Yao, Y., Stroud, J. C., Wang, Z. Z. & Chen, L. Crystal structure of the extracellular domain of nAChR a1 bound to a-bungarotoxin at 1.94Åresolution. Nature Neurosci. 10, 953-962 (2007).
38. Lee, W. Y. & Sine, S. M. Principal pathway coupling agonist binding to channel gating in nicotinic receptors. Nature 438, 243-247 (2005).
39. Akabas, M. H. Using molecular dynamics to elucidate the structural basis for function in pLGICs. Proc. Natl Acad. Sci. USA 110, 16700-16701 (2013).
40. Baulac, S. et al. First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the c2-subunit gene. Nature Genet. 28, 46-48 (2001).
41. Lape, R., Plested, A. J., Moroni, M., Colquhoun, D. & Sivilotti, L. G. The a1K276E startle disease mutation reveals multiple intermediate states in the gating of glycine receptors. J. Neurosci. 32, 1336-1352 (2012).
42. Xu, M. & Akabas, M. H. Identification of channel-lining residues in the M2 membrane-spanning segment of the GABAA receptor alpha1 subunit. J. Gen. Physiol. 107, 195-205 (1996).
43. Cymes, G. D., Ni, Y. & Grosman, C. Probing ion-channel pores one proton at a time. Nature 438, 975-980 (2005).
44. Unwin, N. & Fujiyoshi, Y. Gating movement of acetylcholine receptor caught by plunge-freezing. J. Mol. Biol. 422, 617-634 (2012).
45. Horenstein, J. & Akabas, M. H. Location of a high affinity Zn21 binding site in the channel ofa1b1c-aminobutyricacidA receptors.Mol.Pharmacol. 53, 870-877(1998).
46. Rajendra, S. et al. Mutation of an arginine residue in the human glycine receptor transforms b-alanine and taurine from agonists into competitive antagonists. Neuron 14, 169-175 (1995).
47. Young, G. T., Zwart, R., Walker, A. S., Sher, E. & Millar, N. S. Potentiation of a7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc. Natl Acad. Sci. USA 105, 14686-14691 (2008).
48. daCosta, C. J., Free, C. R., Corradi, J., Bouzat, C. & Sine, S. M. Single-channel and structural foundations of neuronal a7 acetylcholine receptor potentiation. J. Neurosci. 31, 13870-13879 (2011).
49. Shan, Q., Haddrill, J. L. & Lynch, J. W. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 276, 12556-12564 (2001).
50. Jensen, M. L. et al. The b subunit determines the ion selectivity of the GABAA receptor. J. Biol. Chem. 277, 41438-41447 (2002).
51. Aricescu, A. R., Lu, W. & Jones, E. Y. A time- and cost-efficient systemfor high-level protein production inmammalian cells. Acta Crystallogr.D62, 1243-1250 (2006).
52. Zacharias, D. A., Violin, J. D., Newton, A. C. & Tsien, R. Y. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916 (2002).
53. Nagai, T. et al. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nature Biotechnol. 20, 87-90 (2002).
54. Molday, R. S. & MacKenzie, D. Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes. Biochemistry 22, 653-660 (1983).
55. Oprian, D. D., Molday, R. S., Kaufman, R. J. & Khorana, H. G. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc. Natl Acad. Sci. USA 84, 8874-8878 (1987).
56. Kawate, T. & Gouaux, E. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14, 673-681 (2006).
57. Reeves, P. J., Callewaert, N., Contreras, R. & Khorana, H. G. Structure and functionin rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl Acad. Sci. USA 99, 13419-13424 (2002).
58. Aricescu, A. R. & Owens, R. J. Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology. Curr. Opin. Struct. Biol. 23, 345-356 (2013).
59. Tasneem, A., Iyer, L. M., Jakobsson, E. & Aravind, L. Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol. 6, R4 (2004).
60. Jansen, M., Bali, M. & Akabas, M. H. Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA r1 receptors lacking the large cytoplasmic M3M4 loop. J. Gen. Physiol. 131, 137-146 (2008).
61. Chaudhary, S., Pak, J. E., Gruswitz, F., Sharma, V. & Stroud, R. M. Overexpressing human membrane proteins in stably transfected and clonal human embryonic kidney 293S cells. Nature Protocols 7, 453-466 (2012).
62. Chang, V. T. et al. Glycoprotein structural genomics: solving the glycosylation problem. Structure 15, 267-273 (2007).
63. Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D 61, 651-657 (2005).
64. Parker, J. L. & Newstead, S. Current trends in a-helical membrane protein crystallization: an update. Protein Sci. 21, 1358-1365 (2012).
65. Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Cryst. 43, 186-190 (2009).
66. Hibbs, R. E. & Gouaux, E. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474, 54-60 (2011).
67. McCoy, A. J. et al.Phaser crystallographic software. J.Appl. Crystallogr.40, 658-674 (2007).
68. Terwilliger, T. C. et al. Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. 64, 61-69 (2008).
69. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486-501 (2010).
70. Bricogne, G. et al. BUSTER version 2.11.2. Cambridge, UK (Global Phasing Ltd., 2011).
71. Smart, O. S. et al. Exploiting structure similarity in refinement: automatedNCS and target-structure restraints in BUSTER. Acta Crystallogr. D 68, 368-380 (2012).
72. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12-21 (2010).
73. Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
74. Stuart, D. I., Levine, M., Muirhead, H. & Stammers, D. K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6Å. J. Mol. Biol. 134, 109-142 (1979).
75. Krissinel, E. & Henrick, K. Inference ofmacromolecular assemblies fromcrystalline state. J. Mol. Biol. 372, 774-797 (2007).
76. Deprez, C. et al. Solution structure of the E.coli TolA C-terminal domain reveals conformational changes upon binding to the phage g3p N-terminal domain. J. Mol. Biol. 346, 1047-1057 (2005).
77. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037-10041 (2001).
78. Chovancova, E. et al. CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures. PLOS Comput. Biol. 8, e1002708 (2012).
79. Hattori, M., Hibbs, R. E. & Gouaux, E. A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20, 1293-1299 (2012).
80. Fertig, N. et al. Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology. Comb. Chem. High Through. Screen. 12, 24-37 (2009).
81. Saras, A. et al. Histamine action on vertebrate GABAA receptors: direct channel gating and potentiation of GABA responses. J. Biol. Chem. 283, 10470-10475 (2008).
82. Butts, C. A. et al. Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc. Natl Acad. Sci. USA 106, 6501-6506 (2009).